BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Breaking News: Best of BioWorld: Q1Breaking News: Best of BioWorld Science: Q1
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

Priovant’s brepo impresses in phase II cutaneous sarcoidosis trial

Feb. 6, 2026
By Jennifer Boggs
No Comments
On the heels of an NDA submission for brepocitinib in dermatomyositis, Priovant Therapeutics Inc. disclosed data showing the dual TYK2/JAK1 inhibitor surpassed expectations in a phase II study in cutaneous sarcoidosis, another chronic inflammatory skin condition with limited treatment options, setting the stage for a phase III study set to start this year.
Read More
Trumprx screenshot

Hims in trouble, Novo says no-go as Trumprx.gov debuts

Feb. 6, 2026
By Mari Serebrov and Randy Osborne
No Comments
Trumprx.gov launched with much fanfare late Feb. 5, and the online tool brings promise for the “world’s lowest prices” on prescription drugs. Alongside the website hoopla came word from Hims & Hers Health of its own steep discounts on what’s to be the compounded version of a Trumprx-featured therapy: oral Wegovy (semaglutide) for obesity. Novo Nordisk A/S, Wegovy’s originator, vowed to fight.
Read More

Biopharma money raised by month in 2026 (US$M)

Feb. 6, 2026
Biopharma money raised to-date and by month in 2025, including public, private and other financings.
Read More

Trump’s drug-discount website goes live

Feb. 6, 2026
No Comments
A preview of the next edition of BioWorld, Feb. 6, 2026
Read More
Art concept for mouse model

A humanized mouse mimics Fcγ receptor biology in antibody assays

Feb. 6, 2026
By Mar de Miguel
No Comments
Scientists at Ghent University have created a mouse model that incorporates human versions of the receptors that recognize the fragment crystallizable region of immunoglobulin G, one of the most abundant antibodies in the blood and a key mediator of essential immune functions such as cellular activation, pathogen elimination and the regulation of inflammatory responses.
Read More

Regulatory actions for Feb. 5, 2026

Feb. 5, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acarix, Balt, Cumberland, Hologic, Ingeneron, Oncolytics, TSC.
Read More

Other news to note for Feb. 5, 2026

Feb. 5, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Ayrmid, Biodexa, Biomica, DT Cloud Star, Entera, Evogene, Invacare, Lishan, Opko, Otsuka, Primegen, T2 Biosystems, Zevra.
Read More

In the clinic for Feb. 5, 2026

Feb. 5, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Adagio Medical, Biogen, Immunic, Pharmazz, Spur, Theralase, Tr1x.
Read More

Financings for Feb. 5, 2026

Feb. 5, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Biolab, Exxel, Imbed, Izotropic, Pavmed, Stratus, Third Arc.
Read More

Appointments and advancements for Feb. 5, 2026

Feb. 5, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aprea, Levicept, Lumicell, Mercy Bioanalytics, Nodthera, Providence Medical Technology, Rivus, United Imaging, Zoll.
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 … 9057 9058 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 8, 2026.
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing